AMEH.. $0.1788.. NEW HIGH !!!!!!!!!
10Q and the I-box is updated.. hank
Another period of growth and positive cash flow.. New hospitals and hires consume cash flow but,, the base of renewable sales and penetration into the hospital field continues.. AMEH is /continues to create a nitch in the new reality of hospital admin.. of shared medical professionals necessary for everyday emergencys that arise.. Each Qtr. has demonstrated growth within this particular nitch and IMO it will not decrease anytime in the near future.. AMEH is a hold and mold investment Opp. that has the possibility of becoming a 100 bagger from this level.. hank
APOLLO MEDICAL HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
October 31, 2010 January 31, 2010
ASSETS
CURRENT ASSETS
Cash and cash equivalents $ 501,639 $ 665,737
Accounts receivable, net 643,107 457,517
Receivable from officers 8,616 23,483
Due from affiliate 3,900 2,850
Prepaid expenses 46,235 30,165
Total current assets 1,203,497 1,179,752
Deferred commission cost, net 85,938 114,063
Property and equipment, net 7,865 11,627
TOTAL ASSETS $ 1,297,300 $ 1,305,442
LIABILITIES AND STOCKHOLDERS' DEFICIT
CURRENT LIABILITIES:
Accounts payable and accrued liabilities $ 150,116 $ 104,252
Total current liabilities 150,116 104,252
Convertible notes, net 1,248,186 1,247,582
Total liabilities 1,398,302 1,351,834
STOCKHOLDERS' DEFICIT:
Preferred stock, par value $0.001 ;
5,000,000 shares authorized; none issued - -
Common Stock, par value $0.001; 100,000,000 shares authorized,
27,635,774 and 27,041,328 shares issued and outstanding
as of October 31, 2010 and January 31, 2010 27,636 27,041
Additional paid-in-capital 986,266 939,483
Accumulated deficit (1,343,019 ) (1,241,031 )
Total (329,117 ) (274,507 )
Non-controlling interest 228,115 228,115
Total stockholders' deficit (101,002 ) (46,392 )
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 1,297,300 $ 1,305,442
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements
3
--------------------------------------------------------------------------------
APOLLO MEDICAL HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE THREE AND NINE MONTH PERIODS ENDED OCTOBER 31, 2010 AND 2009
(UNAUDITED)
For the Three Month Periods Ended For the Nine Month Periods Ended
October 31, October 31,
2010 2009 2010 2009
NET REVENUE $ 1,019,078 $ 616,975 $ 2,861,658 $ 1,699,100
COST OF REVENUE 868,119 455,183 2,407,524 1,262,430
GROSS PROFIT 150,959 161,792 454,134 436,670
Operating expenses:
General and administrative 152,013 139,557 427,720 434,225
Depreciation 2,330 9,622 8,330 30,297
Total operating expenses 154,343 149,179 436,050 464,522
INCOME/(LOSS) FROM OPERATIONS (3,384 ) 12,613 18,084 (27,852 )
OTHER INCOME/(EXPENSES):
Interest expense (31,748 ) (15,738 ) (94,736 ) (25,546 )
Financing cost (9,375 ) (25,000 ) (28,125 ) (25,000 )
Other income 4,292 - 4,389 -
Total other expenses (36,831 ) (40,738 ) (118,472 ) (50,546 )
LOSS BEFORE INCOME TAXES (40,215 ) (28,125 ) (100,388 ) (78,398 )
Provision for Income Tax 800 800 1,600 1,600
NET LOSS $ (41,015 ) $ (28,925 ) $ (101,988 ) $ (79,998 )
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING,
BASIC AND DILUTED 27,635,774 26,805,493 27,370,367 26,260,574
*BASIC AND DILUTED NET LOSS PER SHARE $ (0.00 ) $ (0.00 ) $ (0.00 ) $ (0.00 )
*Weighted average number of shares used to compute basic and diluted loss per share is the same since the effect of dilutive securities is anti-dilutive.
